Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients

Clinical trial NCT04189276 · UNKNOWN

Trial details

NCT number: NCT04189276
Sponsor: Tasly Tianjin Biopharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis B Virus (HBV)

Start date: 2019-12-10
Primary completion: 2021-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.